The healthcare technology and benefits administration company said the amendments cut near-term debt service by more than $26 million and are meant to ease liquidity pressure and support growth plans.
Marpai said it has signed debt restructuring agreements with its principal lenders, JGB Capital in May 2026 and AXA S.A. in July 2026, to reduce near-term debt service costs and better match repayment obligations with projected cash flows. The company said the changes are designed to relieve immediate liquidity pressure, support operations and give it more financial flexibility. Under the JGB Second Amendment Agreement, the maturity date of debentures issued under the JGB Purchase Agreement was extended by one year to April 15, 2028, with a revised amortization schedule and certain restructuring and exit payments. Under the AXA Second Amendment Agreement, Marpai said it replaced the prior repayment schedule with new minimum annual payments and extended maturity by an additional year to December 31, 2029. CEO Damien Lamendola said the revised debt service profile reduces near-term debt service by over $26 million, which the company expects will preserve capital for investment, technology platform development, market share expansion and long-term growth.